Activation of the poly(ADP-ribose) polymerase pathway in human heart failure. - Wikidata - awgldk - TriplyDB

Activation of the poly(ADP-ribose) polymerase pathway in human heart failure.

Activation of the poly(ADP-ribose) polymerase pathway in human heart failure.

http://www.wikidata.org/entity/Q35113704

about

Cardio-protection of salvianolic acid B through inhibition of apoptosis network Hyperglycemia as a Risk Factor of Ischemic Stroke Delayed activation of caspase-independent apoptosis during heart failure in transgenic mice overexpressing caspase inhibitor CrmA Reduced estradiol-induced vasodilation and poly-(ADP-ribose) polymerase (PARP) activity in the aortas of rats with experimental polycystic ovary syndrome (PCOS).Signaling mechanism of poly(ADP-ribose) polymerase-1 (PARP-1) in inflammatory diseases.Distinct cardiodynamic and molecular characteristics during early and late stages of sepsis-induced myocardial dysfunction.Reactive oxygen and nitrogen species in pathogenesis of vascular complications of diabetes.Salvage of nicotinamide adenine dinucleotide plays a critical role in the bioenergetic recovery of post-hypoxic cardiomyocytes.Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease.Therapeutic applications of PARP inhibitors: anticancer therapy and beyond Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction.Role of AIF in cardiac apoptosis in hypertrophic cardiomyocytes from Dahl salt-sensitive rats.Adapter proteins and promoter regulation of the angiotensin AT2 receptor--implications for cardiac pathophysiology.PARP inhibitors: polypharmacology versus selective inhibition.Oxidative Stress-Related Parthanatos of Circulating Mononuclear Leukocytes in Heart Failure.PARP1 promote autophagy in cardiomyocytes via modulating FoxO3a transcription

P2860

Q28476812-4F7BF0E4-B52D-4CE0-A3BA-3ABAB41CFA61 Q34342764-B36EC70B-BB95-4E5C-A8A7-CCA86629B97F Q34357781-E19E1C23-E4AA-40F0-9D2F-9F3A98B66652 Q34650147-7DA12FE3-6463-4B0E-9D62-60EFFFDDB1AA Q34755657-22076F2A-5408-40CF-8156-37A4971E4E77 Q36002854-3684DC30-0012-4ADB-A1CB-BC65C3FBB271 Q36049201-CD2A80A8-56F2-4184-8911-B66381C9418E Q36211215-C5263B1B-61E7-45A9-AFB0-58B4E4652DE6 Q36426742-2E6B277F-736A-4D2A-8AC5-38760EC855A7 Q36734840-214CC666-B56F-47D9-9274-3334B423AE93 Q36853236-8A81C0C9-7907-4766-BB48-882C41B1C50E Q37230827-6DD33957-3A20-46CB-901B-554D9FBD50FB Q37467834-4858F7A8-24C3-400F-BF95-249A818928CD Q37598488-769C119B-E6BB-4FC2-99B3-BEC7F134137C Q38100299-33C55E5B-A797-4845-9013-94851DC151DA Q47283225-C9CACFBD-8C7E-4939-A82A-8426A423D27A Q57461771-58356FC9-E79E-4F2D-BC65-CEEF3F62F16B

P2860

Activation of the poly(ADP-ribose) polymerase pathway in human heart failure.

http://www.wikidata.org/entity/Q35113704

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Activation of the poly(ADP-ribose) polymerase pathway in human heart failure.

@ast

Activation of the poly(ADP-ribose) polymerase pathway in human heart failure.

@en

type

label

Activation of the poly(ADP-ribose) polymerase pathway in human heart failure.

@ast

Activation of the poly(ADP-ribose) polymerase pathway in human heart failure.

@en

prefLabel

Activation of the poly(ADP-ribose) polymerase pathway in human heart failure.

@ast

Activation of the poly(ADP-ribose) polymerase pathway in human heart failure.

@en

P1433

Q35113704-63D52AAB-1DC5-4F6A-86EF-28D6A1D8AD8D

P1476

Q35113704-96E14479-7593-4CCA-B6D0-6773E3053BB8

P2093

Q35113704-092213F0-FE7F-4392-AE87-E88E08D8B243

Q35113704-094C3CD1-F6E5-4A67-B8B5-8A1458FEDF58

Q35113704-3A37F8E0-AB31-4EF4-AF1E-3E93E563B306

Q35113704-56C82D51-E566-430B-9466-0FA94367A049

Q35113704-7A8EB9B9-CC35-40D4-BAEC-790A149CF156

Q35113704-8C2190E4-C1B2-4AEF-8D88-9E17D7445484

Q35113704-90326EAE-D44C-4C12-B745-0D6BF45D1CD0

Q35113704-97D9C303-A856-4254-865E-6BC9879E391A

Q35113704-A52E739A-EFBA-4805-8FD8-577C14D8840A

Q35113704-D40BC64D-6FAD-4804-9123-418991E7A007

P2860

Q35113704-08BDC94E-D731-420E-8873-C2313FAE07C5

Q35113704-16694A08-30DA-461C-9C27-8AFB1D65429C

Q35113704-37A71F4F-4D57-4865-B228-E3C6F7A1D35F

Q35113704-41BEFDA8-4AC6-4101-BE8A-72B2E30C218C

Q35113704-51E5E129-AF23-468E-B7D8-C5606613F4F0

Q35113704-5931023F-915B-42C1-AA6F-A4D8F6BC5B60

Q35113704-5A5FD7ED-02ED-4AD0-87A4-C1E24996E9A7

Q35113704-5FB607F2-002F-4180-9751-E4A4BF00873D

Q35113704-6029F3CC-D984-45B5-84B7-731129E9F604

Q35113704-61105A83-DB75-4E05-B55A-7A4A17A92411

P2888

Q35113704-D306E220-B082-4FEB-9D01-D3ACA047B359

P304

Q35113704-FE68DA10-11C9-4D31-BB39-2763648A2B98

P31

Q35113704-487E793D-3E5B-49E2-B96C-00818719DE61

P356

Q35113704-698DDB56-68E3-4FD6-8A2E-56AE1A0676B1

P407

Q35113704-88792960-CF89-42E7-B146-7AFB094F0581

P433

Q35113704-E3088EA9-D04D-4C47-B615-070D310D6DE8

P478

Q35113704-26F34BAD-CC01-492D-B7BD-D1352093E1D4

P50

Q35113704-43E7DBBB-D2D3-42FD-94D1-ABDEDC5898F7

Q35113704-5202E900-E79E-48F8-AA92-CC1AECC4EB7D

P577

Q35113704-4D59054A-0F93-4DD5-8AB6-3A4A837EB89C

P6179

Q35113704-2E6ED326-CC26-4AAD-84A9-68E31A81BF9E

P698

Q35113704-6514FF7B-942B-4F1B-97A4-1D54EBE23FF6

P921

Q35113704-990DDE81-10A3-449C-81E8-47C98B997CA8

P932

Q35113704-DA4A7C84-2CC2-44CF-9548-1A91E02E3667

P356

2006-00043.MOLNAR

P1433

Molecular Medicine

P1476

Activation of the poly(ADP-ribose) polymerase pathway in human heart failure

@en

P2093

Andrea Molnár

http://www.w3.org/2001/XMLSchema#string

András Varró

http://www.w3.org/2001/XMLSchema#string

Csaba Szabó

http://www.w3.org/2001/XMLSchema#string

István Edes

http://www.w3.org/2001/XMLSchema#string

Julius Gy Papp

http://www.w3.org/2001/XMLSchema#string

Miklós Vaszily

http://www.w3.org/2001/XMLSchema#string

Viktória Szüts

http://www.w3.org/2001/XMLSchema#string

Zoltán Galajda

http://www.w3.org/2001/XMLSchema#string

Zoltán Papp

http://www.w3.org/2001/XMLSchema#string

Zsolt Bagi

http://www.w3.org/2001/XMLSchema#string

P2860

Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update

Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies

The biochemistry of apoptosis

Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications.

Oxygen, oxidative stress, hypoxia, and heart failure.

Matrix metalloproteinases in the progression of heart failure: potential therapeutic implications.

Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure.

Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death

The therapeutic potential of poly(ADP-ribose) polymerase inhibitors.

Role of nitric oxide in matrix remodeling in diabetes and heart failure.

P2888

2006-00043.molnar

P304

143-152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2119/2006-00043.MOLNAR

http://www.w3.org/2001/XMLSchema#string

P407

P433

7-8

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1068964945

http://www.w3.org/2001/XMLSchema#string

P698

17088946

http://www.w3.org/2001/XMLSchema#string

P921

P932

1626594

http://www.w3.org/2001/XMLSchema#string